Related Experiment Video
Updated: Apr 6, 2026

A Colorimetric Assay that Specifically Measures Granzyme B Proteolytic Activity: Hydrolysis of Boc-Ala-Ala-Asp-S-Bzl
Published on: November 28, 2014
Increased Granzyme K+ CD8+ T cells and senescent subset in Behçet's disease
Heera Lee1, Soo-Jin Lee2, Young Joon Park2
1Department of Dermatology, Ewha Womans University College of Medicine, Seoul, Republic of Korea.
Objectives:
Behçet's disease (BD) is a chronic inflammatory condition with immune system dysregulation. Recent evidence suggests proinflammatory roles of extracellular granzyme K (GzmK), particularly in aged immune cells. This study investigated GzmK-expressing CD8+ T cells and their senescent subset in BD pathology.
Methods:
We analysed lymphocyte subsets in blood samples from 19 active BD (aBD), 19 inactive BD (iaBD), and 19 healthy controls (HC) using flow cytometry and granzymes, as well as IL-6 using enzyme-linked immunosorbent assay.
Results:
Active BD patients showed significantly higher serum GzmK levels and GzmK+CD8+ T cells with advanced differentiation markers. GzmK+CD8+ T cells positively correlated with TNF-α+ and IFN-γ+ lymphocytes. The senescent subset (GzmK+CD27-CD28-CD57+CD8+) specifically correlated with TNF-α+ lymphocytes, indicating involvement in TNF-α-centered inflammatory pathways.
Conclusion:
GzmK+CD8+ T cells and their senescent counterparts are not merely biomarkers of disease activity but may function as extracellular proinflammatory effectors that amplify the TNF-α-mediated inflammatory loop in BD. Targeting the GzmK-senescence axis represents a promising therapeutic strategy for managing chronic inflammation in BD.
More Related Videos
14:01Far-Red Fluorescent Senescence-Associated β-Galactosidase Probe for Identification and Enrichment of Senescent Tumor Cells by Flow Cytometry
Published on: September 13, 2022
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021